Position in GHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$159,500,947
+$76,071,509 QoQ
Shares Held
5,933,815
0.0% QoQ
Ownership
8.64%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#5
of 62 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RTW INVESTMENTS, LP holds $9,530,420,260 across 63 Biotechnology names. GHRS ranks #20 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,993,687 | $1,070,510,234 | |
| 2 | ARGX |
Argenx SE
|
709,446 | $658,202,715 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
7,746,415 | $631,875,071 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
5,061,175 | $620,398,831 | |
| 5 | CGON |
CG Oncology, Inc.
|
8,514,590 | $604,961,619 | |
| 6 | INSM |
INSMED Inc
|
4,842,880 | $516,347,865 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
13,900,620 | $434,533,381 | |
| 8 | SYRE |
Spyre Therapeutics, Inc.
|
4,251,996 | $377,492,204 |
All Filings in GHRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $159,500,947 | 5,933,815 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $83,429,438 | 5,933,815 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $75,359,450 | 5,933,815 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $79,644,765 | 5,569,564 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $67,538,170 | 5,540,457 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $60,662,452 | 5,499,769 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $60,662,452 | 5,499,769 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $23,289,903 | 3,327,129 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $22,258,493 | 3,327,129 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $38,794,324 | 3,327,129 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $35,467,195 | 3,327,129 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,297,348 | 3,327,129 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $33,437,646 | 3,327,129 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $25,734,674 | 2,168,957 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,329,966 | 2,168,957 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $21,082,262 | 2,168,957 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,203,280 | 2,168,957 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,646,190 | 2,168,957 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $39,670,223 | 2,168,957 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $50,601,766 | 2,168,957 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $47,847,191 | 2,168,957 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $47,131,435 | 2,168,957 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||